Marc Belsky
2019 - Kezar Life Sciences
In 2019, Marc Belsky earned a total compensation of $1.6M as Chief Financial Officer at Kezar Life Sciences.
Compensation breakdown
| Non-Equity Incentive Plan | $105,000 |
|---|---|
| Option Awards | $1,104,078 |
| Salary | $375,000 |
| Other | $11,794 |
| Total | $1,595,872 |
Belsky received $1.1M in option awards, accounting for 69% of the total pay in 2019.
Belsky also received $105K in non-equity incentive plan, $375K in salary and $11.8K in other compensation.
Rankings
In 2019, Marc Belsky's compensation ranked 7,031st out of 13,971 executives tracked by ExecPay. In other words, Belsky earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,031 out of 13,971 | 50th |
Division Manufacturing | 2,694 out of 5,701 | 53rd |
Major group Chemicals And Allied Products | 991 out of 2,200 | 55th |
Industry group Drugs | 840 out of 1,886 | 56th |
Industry Pharmaceutical Preparations | 618 out of 1,398 | 56th |
Source: SEC filing on April 29, 2020.
Belsky's colleagues
We found three more compensation records of executives who worked with Marc Belsky at Kezar Life Sciences in 2019.